We are live on ! Find out more
INZY

Inozyme Pharma

Delisted

INZY was delisted on the 30th of June, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
NMC
1
NEA Management Company
Maryland
$10M
DM
2
Deerfield Management
New York
$9.59M
SI
3
Sofinnova Investments
California
$8.3M
Adage Capital Partners
4
Adage Capital Partners
Massachusetts
$7.14M +$869K +147,644 +9%
PBPIA
5
Pivotal bioVenture Partners Investment Advisor
California
$6.51M
RSCM
6
Rock Springs Capital Management
Maryland
$4.88M +$1.91M +324,729 +37%
SCM
7
Suvretta Capital Management
New York
$4.14M
CA
8
CHI Advisors
New York
$3.65M
BlackRock
9
BlackRock
New York
$3.59M +$244K +41,402 +5%
Fidelity Investments
10
Fidelity Investments
Massachusetts
$2.49M +$1.26K +214 +0%
Janus Henderson Group
11
Janus Henderson Group
$2.12M +$2.33M +395,610 +316%
Vanguard Group
12
Vanguard Group
Pennsylvania
$2M +$5.26K +894 +0.2%
JP Morgan Chase
13
JP Morgan Chase
New York
$1.27M -$79.2K -13,454 -4%
MB
14
MPM BioImpact
Massachusetts
$1.21M -$44.9K -7,635 -3%
State Street
15
State Street
Massachusetts
$773K +$11.2K +1,903 +1%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$760K +$11.7K +1,988 +1%
Northern Trust
17
Northern Trust
Illinois
$466K -$40.8K -6,939 -6%
BBA
18
Baker Bros. Advisors
New York
$438K
Citadel Advisors
19
Citadel Advisors
Florida
$402K -$51.1K -8,681 -8%
BCM
20
Bridgeway Capital Management
Texas
$235K -$118K -20,000 -26%
Nuveen
21
Nuveen
North Carolina
$172K +$7.73K +1,313 +3%
Bank of New York Mellon
22
Bank of New York Mellon
New York
$164K -$6.96K -1,183 -3%
Charles Schwab
23
Charles Schwab
California
$125K -$34.9K -5,930 -16%
OMC
24
Overbrook Management Corp
New York
$68K
Morgan Stanley
25
Morgan Stanley
New York
$64K -$20.6K -3,503 -18%